Renovaro Profit Margin

Renovaro (RENB) currently reports a profit margin of -66490.45% as of March 2026. That compares with -55769.98% in the prior-year period — down 19.2% year over year. That is below the Healthcare sector average of 15.58%. Use the charts on this page to explore Renovaro's profit margin history and peer comparisons.

Renovaro's profit margin decreased from -55769.98% to -66490.45% — a 19.2% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Renovaro's profit margin of -66490.45% is lower than the Healthcare sector average of 15.58%. That is roughly 426757.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Renovaro's current -66490.45% should be judged against Healthcare norms (sector average: 15.58%) and against RENB's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -66490.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 15.58%. From there, open related valuation or income-statement pages for Renovaro, and consider following RENB for alerts when major investors trade the stock.